节点文献

金黄杆菌临床分离株β-内酰胺酶及耐药性分析

Analysis of beta-lactamase production and antibiotic resistance in clinically isolated Chryseobacterium spp

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 林祥宏徐元宏陈晓莉朱梅凌华志李涛王中新

【Author】 LIN Xianghong,XU Yuanhong,CHEN Xiaoli,ZHU Mei,LING Huazhi,LI Tao,WANG Zhongxin(Department of Clinical Laboratory,the First Affiliated Hospital of Anhui Medical University,Center of Control and Supervision for Bacterial Resistance of Anhui Province,Hefei 230022,China)

【机构】 安徽医科大学第一附属医院检验科安徽省细菌耐药监控中心 合肥230022安徽医科大学第一附属医院检验科安徽省细菌耐药监控中心合肥230022

【摘要】 目的了解临床分离的金黄杆菌耐药特性和β-内酰胺酶产生情况。方法琼脂稀释法检测50株金黄杆菌对18种抗生素的MIC,改良的三纸片增效法和四槽、五槽三维试验法检测金黄杆菌金属β-内酰胺酶(MBL)、超广谱β-内酰胺酶(ES-BL)和AmpC酶。结果50株金黄杆菌对亚胺培南、美罗培南的耐药率为92%、88%,氨曲南为92%,阿米卡星和β-内酰胺抗生素的耐药率均大于40%,显示具有高度耐药性。加替沙星、左氧氟沙星和利福平的MIC90分别为4、8、8μg/ml,表现出很强的抗菌活性。环丙沙星、万古霉素、哌拉西林/他唑巴坦和头孢哌酮/舒巴坦也具有良好的抗菌活性。50株金黄杆菌MBL、ES-BL、AmpC酶产酶率分别为68.0%、26.0%、0.0%。脑膜败血性金黄杆菌中产MBL73.7%,同时产MBL和ESBL42.1%,单产ESBL5.3%。产吲哚金黄杆菌MBL产酶率80.0%。结论金黄杆菌具有高度的多重耐药现象和MBL、ESBL高检出率,应该合理使用抗生素,保护易感人群,准确、及时地做好病原学诊断和耐药性监测并给予正确的治疗。

【Abstract】 Objective To investigate the antibiotic resistance and the producing rate of beta-lactamase in clinically isolated Chryseobacterium spp.Methods The MIC of 18 antibiotics to 50 strains of Chryseobacterium spp was detected by agar dilution method.The beta-lactamase(MBL,ESBL and AmpC)of Chryseobacterium spp was detected by three-disc synergy test and some modified three-dimension tests.Results The percentages of antibiotic resistance of 50 clinically isolated Chryseobacterium spp to imipenem,meropenem and aztreonam were 92%,88% and 92% respectively,to amikacin and beta-lactamase antibiotics were also more than 40%.However,gatifloxacin,levofloxacin and rifampin showed better antimicrobiotial activity to Chryseobacterium spp compared with other antibiotics in MIC,and their MIC90 were 4,8,8 μg/ml respectively.Ciprofloxacin,vancomycin,cepoperazon-sulbactam and piperacillin-tazobactam showed good antimicrobiotical activity to some extent.The producing rates of MBL,ESBL and AmpC in 50 strains of Chryseobacterium spp were 68.0%,26.0%,and 0 respectively.The rates of MBL production in Chryseobacterium meningosepticum and Chryseobacterium indologenes were 73.7% and 80.0% respectively.In Chryseobacterium meningosepticum 42.1% produced MBL and ESBL simultaneously.Conclusions Chryseobacterium spp showed high multi-drug resistance and high production of beta-lactamase,so the treatment for it may be difficult.Antimicrobial agents should be chosen reasonably under correct directions of clinical laboratory examination.

【基金】 安徽省十五攻关二期科研课题(040130583)
  • 【文献出处】 临床检验杂志 ,Chinese Journal of Clinical Laboratory Science , 编辑部邮箱 ,2007年05期
  • 【分类号】R446.5
  • 【被引频次】7
  • 【下载频次】94
节点文献中: 

本文链接的文献网络图示:

本文的引文网络